Reproductive signaling
Used for HPG-axis conversations involving GnRH, LH, FSH, and downstream sex-hormone signaling.
Reproductive hormone signaling
Kisspeptin is discussed for clinician-guided HPG-axis support, reproductive hormone signaling, libido, fertility planning, and hormone-balance conversations.
Overview
Kisspeptin is a naturally occurring neuropeptide involved in the hypothalamic-pituitary-gonadal axis. It signals through the KISS1 receptor and helps stimulate GnRH, which then influences LH and FSH release.
IPS reviews Kisspeptin in context: reproductive goals, libido, menstrual or ovulatory history, testosterone or estrogen concerns, fertility planning, metabolic health, medications, and whether hormone testing or specialist care is needed.
IPS access
IPS includes Kisspeptin as a clinician-guided option. The public website does not list dosage, pricing, or source details; those are reviewed privately during consultation.
Used for HPG-axis conversations involving GnRH, LH, FSH, and downstream sex-hormone signaling.
May be discussed when reproductive wellness, libido, ovulatory function, or hormonal balance are part of the goal.
Hormone labs, symptom history, fertility plans, and medication use help determine candidacy.
Mechanism
Kisspeptin is commonly framed around GnRH stimulation and downstream LH and FSH signaling. IPS keeps the discussion tied to physiology, lab context, and whether this pathway fits the person's goals and medical history.
Kisspeptin helps signal GnRH neurons, which influence reproductive hormone cascades.
These pituitary signals are part of ovulation, spermatogenesis, testosterone production, and estrogen signaling.
Some patients ask about Kisspeptin for libido, fertility support, cycle concerns, or hormone optimization.
The educational context also discusses metabolic signaling, so blood sugar, weight, and energy context may matter.
Process
Review reproductive goals, libido, cycle or fertility history, testosterone or estrogen concerns, and current therapies.
Screen pregnancy-related factors, fertility care, hormone-sensitive conditions, medications, and lab needs.
If appropriate, your clinician reviews candidacy, timing, monitoring, expectations, and how it fits the broader plan.
Follow-up tracks tolerance, symptoms, hormone markers when appropriate, and whether adjustments are needed.
Safety & candidacy
IPS reviews fertility goals, hormone-sensitive conditions, pregnancy-related factors where applicable, medication use, endocrine diagnoses, cancer history, and whether specialist involvement is needed before discussing Kisspeptin.
Questions
Yes. Kisspeptin is in the IPS available peptide list. Public pages do not display dosage or pharmacy/source details.
It is discussed around HPG-axis signaling, GnRH activity, reproductive hormone balance, libido, and fertility-related conversations.
No. Fertility, endocrine, and hormone concerns should be evaluated and managed by the appropriate clinician.
People using hormone therapy or fertility medications, people with hormone-sensitive conditions, and anyone with pregnancy-related factors or complex endocrine history need careful review.
Contact
Complete the form and IPS will follow up about consultation scheduling and next steps.